418 related articles for article (PubMed ID: 24881141)
1. [Diagnosis and prognosis of gliomas--current prospects of molecular diagnostics].
Haapasalo J; Hyartt A; Salmi M; Nordfors K; Lahtela SL; Kähkönen M; Helén P; Haapasalo H
Duodecim; 2014; 130(9):893-901. PubMed ID: 24881141
[TBL] [Abstract][Full Text] [Related]
2. [Advance of molecular subtyping and precise treatment for gliomas].
Hua W; Mao Y
Zhonghua Wai Ke Za Zhi; 2017 Jan; 55(1):63-66. PubMed ID: 28056258
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice].
Fontaine D; Vandenbos F; Lebrun C; Paquis V; Frenay M
Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359
[TBL] [Abstract][Full Text] [Related]
4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
5. Repeated molecular testing in gliomas: a retrospective study of 53 cases.
Mahajan D; Prayson RA
Am J Clin Pathol; 2009 Jul; 132(1):118-24. PubMed ID: 19864242
[TBL] [Abstract][Full Text] [Related]
6. Input of molecular analysis in medical management of primary brain tumor patients.
Idbaih A; Duran-Peña A; Bonnet C; Ducray F
Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
[TBL] [Abstract][Full Text] [Related]
7. Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management.
Taylor JW; Chi AS; Cahill DP
Oncology (Williston Park); 2013 Jun; 27(6):504-14. PubMed ID: 23909061
[TBL] [Abstract][Full Text] [Related]
8. A surgical strategy for lower grade gliomas using intraoperative molecular diagnosis.
Koriyama S; Nitta M; Kobayashi T; Muragaki Y; Suzuki A; Maruyama T; Komori T; Masui K; Saito T; Yasuda T; Hosono J; Okamoto S; Shioyama T; Yamatani H; Kawamata T
Brain Tumor Pathol; 2018 Jul; 35(3):159-167. PubMed ID: 29980868
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic gliomas in adults: an update.
Izquierdo C; Joubert B; Ducray F
Curr Opin Oncol; 2017 Nov; 29(6):434-442. PubMed ID: 28901965
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnostics of gliomas: the clinical perspective.
Tabatabai G; Stupp R; van den Bent MJ; Hegi ME; Tonn JC; Wick W; Weller M
Acta Neuropathol; 2010 Nov; 120(5):585-92. PubMed ID: 20862485
[TBL] [Abstract][Full Text] [Related]
11. ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.
Wiestler B; Capper D; Holland-Letz T; Korshunov A; von Deimling A; Pfister SM; Platten M; Weller M; Wick W
Acta Neuropathol; 2013 Sep; 126(3):443-51. PubMed ID: 23904111
[TBL] [Abstract][Full Text] [Related]
12. Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas.
Reddy KS
Cancer Genet Cytogenet; 2008 Jul; 184(2):77-86. PubMed ID: 18617055
[TBL] [Abstract][Full Text] [Related]
13. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
[TBL] [Abstract][Full Text] [Related]
14. [Towards a molecular classification of gliomas].
Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M
Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387
[TBL] [Abstract][Full Text] [Related]
15. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.
Law M; Brodsky JE; Babb J; Rosenblum M; Miller DC; Zagzag D; Gruber ML; Johnson G
J Magn Reson Imaging; 2007 Jun; 25(6):1113-9. PubMed ID: 17520715
[TBL] [Abstract][Full Text] [Related]
16. Foundations of the Diagnosis and Management of Low-Grade Gliomas.
Norman S; Juthani RG; Magge R
World Neurosurg; 2022 Oct; 166():306-312. PubMed ID: 36192862
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing: 1p/19q Co-Deletion Analysis of Gliomas.
Dubbink HJ; Atmodimedjo PN; van Marion R; Krol NMG; Riegman PHJ; Kros JM; van den Bent MJ; Dinjens WNM
J Mol Diagn; 2016 Sep; 18(5):775-786. PubMed ID: 27461031
[TBL] [Abstract][Full Text] [Related]
18. Gliomas with 1p/19q codeletion: a.k.a. oligodendroglioma.
Cairncross G; Jenkins R
Cancer J; 2008; 14(6):352-7. PubMed ID: 19060598
[TBL] [Abstract][Full Text] [Related]
19. [Multidisciplinar approach to the management of gliomas].
Moura B; Migliorini D; Bourhis J; Daniel R; Levivier M; Hottinger AF
Rev Med Suisse; 2016 Apr; 12(516):821-5. PubMed ID: 27281939
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnostics of gliomas.
Nikiforova MN; Hamilton RL
Arch Pathol Lab Med; 2011 May; 135(5):558-68. PubMed ID: 21526954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
